Beaugerie L - Search Results

1

Predicting, Preventing, and Managing Treatment-Related Complications in Patients With Inflammatory Bowel Diseases.

Beaugerie L, Rahier JF, Kirchgesner J. Beaugerie L, et al. Clin Gastroenterol Hepatol. 2020 May;18(6):1324-1335.e2. doi: 10.1016/j.cgh.2020.02.009. Epub 2020 Feb 12. Clin Gastroenterol Hepatol. 2020. PMID: 32059920 Free article. Review.

2

[What is inflammatory bowel disease?].

Beaugerie L. Beaugerie L. Rev Prat. 2005 May 15;55(9):943-8. Rev Prat. 2005. PMID: 16052965 Review. French.

3

Specific clinical and biological features characterize inflammatory bowel disease associated colorectal cancers showing microsatellite instability.

Svrcek M, El-Bchiri J, Chalastanis A, Capel E, Dumont S, Buhard O, Oliveira C, Seruca R, Bossard C, Mosnier JF, Berger F, Leteurtre E, Lavergne-Slove A, Chenard MP, Hamelin R, Cosnes J, Beaugerie L, Tiret E, Duval A, Fléjou JF. Svrcek M, et al. Among authors: beaugerie l. J Clin Oncol. 2007 Sep 20;25(27):4231-8. doi: 10.1200/JCO.2007.10.9744. J Clin Oncol. 2007. PMID: 17878476

4

Disease activity and cancer risk in inflammatory bowel disease associated with primary sclerosing cholangitis.

Sokol H, Cosnes J, Chazouilleres O, Beaugerie L, Tiret E, Poupon R, Seksik P. Sokol H, et al. Among authors: beaugerie l. World J Gastroenterol. 2008 Jun 14;14(22):3497-503. doi: 10.3748/wjg.14.3497. World J Gastroenterol. 2008. PMID: 18567077 Free PMC article.

5

Incidence of benign upper respiratory tract infections, HSV and HPV cutaneous infections in inflammatory bowel disease patients treated with azathioprine.

Seksik P, Cosnes J, Sokol H, Nion-Larmurier I, Gendre JP, Beaugerie L. Seksik P, et al. Among authors: beaugerie l. Aliment Pharmacol Ther. 2009 May 15;29(10):1106-13. doi: 10.1111/j.1365-2036.2009.03973.x. Epub 2009 Feb 15. Aliment Pharmacol Ther. 2009. PMID: 19222411 Free article.

6

Inflammatory bowel disease and lymphoproliferative disorders: the dust is starting to settle.

Sokol H, Beaugerie L. Sokol H, et al. Among authors: beaugerie l. Gut. 2009 Oct;58(10):1427-36. doi: 10.1136/gut.2009.181982. Gut. 2009. PMID: 19749141

7

Noncolorectal malignancies in inflammatory bowel disease: more than meets the eye.

Beaugerie L, Sokol H, Seksik P. Beaugerie L, et al. Dig Dis. 2009;27(3):375-81. doi: 10.1159/000228577. Epub 2009 Sep 24. Dig Dis. 2009. PMID: 19786768 Review.

8

Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study.

Beaugerie L, Brousse N, Bouvier AM, Colombel JF, Lémann M, Cosnes J, Hébuterne X, Cortot A, Bouhnik Y, Gendre JP, Simon T, Maynadié M, Hermine O, Faivre J, Carrat F; CESAME Study Group. Beaugerie L, et al. Lancet. 2009 Nov 7;374(9701):1617-25. doi: 10.1016/S0140-6736(09)61302-7. Lancet. 2009. PMID: 19837455

9

Risk factors for neoplasia in inflammatory bowel disease patients with pancolitis.

Bergeron V, Vienne A, Sokol H, Seksik P, Nion-Larmurier I, Ruskone-Fourmestraux A, Svrcek M, Beaugerie L, Cosnes J. Bergeron V, et al. Among authors: beaugerie l. Am J Gastroenterol. 2010 Nov;105(11):2405-11. doi: 10.1038/ajg.2010.248. Epub 2010 Jun 15. Am J Gastroenterol. 2010. PMID: 20551939

10

Usefulness of co-treatment with immunomodulators in patients with inflammatory bowel disease treated with scheduled infliximab maintenance therapy.

Sokol H, Seksik P, Carrat F, Nion-Larmurier I, Vienne A, Beaugerie L, Cosnes J. Sokol H, et al. Among authors: beaugerie l. Gut. 2010 Oct;59(10):1363-8. doi: 10.1136/gut.2010.212712. Epub 2010 Jun 29. Gut. 2010. PMID: 20587545

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

365 results

Search Page